CRS: BJMC
Position: Pharmacist of Record
CRS: Whitman-Walker
CRS: JHU
Position: Pharmacist, PharmD, Investigational Drug Pharmacy
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
